| |
|
|
CENTC Advisory Board
 |
Emilio Bunel received his Ph.D. at Caltech
with Prof. John Bercaw after completing his Master’s degree in Chemical Engineering at the
University of Chile. He has held research positions related to catalysis at DuPont, Eli Lilly,
Amgen and Pfizer before joining the Argonne National Labs. In 2008, he was named Director
of Chemical Sciences and Engineering at ANL. His research interests include: Organometallic synthesis
with particular emphasis on applications to homogeneous catalysis, in-situ characterization techniques,
high throughput techniques applied to catalyst discovery, and catalysis applied to energy problems such
as carbon dioxide activation and water splitting.
|
| |
 |
Charles P. Casey received his Ph.D. from MIT in 1967 where
he did graduate research with George M. Whitesides on organocopper compounds.
In 1968, he joined the faculty at the University of Wisconsin-Madison where he is now Homer
B. Adkins Emeritus Professor of Chemistry.
Professor Casey's research focuses on mechanistic organometallic chemistry.
The mechanisms of important catalytic processes including hydroformylation, hydrogenation,
and alkene polymerization have been explored. He is currently
working on new hydrogenation catalysts that operate by
simultaneous delivery of a hydride and a proton to polar
substrates. He is author of more than 250 papers in
organometallic chemistry and served as President of the American
Chemical Society in 2004.
|
 |
Edward Grabowski received his
Ph.D. from the University of Rochester in 1965 before
joining the Process Research Department at the Merck Research
Labs. He recently retired as Vice President of
Chemistry (Process Research) after over 38 years at Merck & Co.
He now serves as a consultant to the pharmaceutical industry, recently
completed an eight year term as a member of the Organic Synthesis Editorial Board,
and served as an Advisory Board Member and Chair of the ACS Petroleum Research Fund.
Dr. Grabowski is a co-author on approximately 100 research papers and reviews,
a co-inventor on more than 50 US patents, and has presented over 150 invited
lectures at symposia and universities over the years. His research interests
were program-driven and are focused on the design and development of practical
syntheses of MRL’s drug candidates and products. They have encompassed
contributions in synthetic and physical organic chemistry.
|
 |
Bob Hembre
completed his Ph.D. studies at Colorado State University, studying
with Jack Norton, after receiving his M.S. from the University
of Wisconsin (with Charles Casey). He was an assistant professor
at the University of Nebraska before joining the Eastman
Chemical Company. He is currently a Principal Research Chemist
at Eastman. |
| |
 |
Jennifer Holmgren is General Manager of the Renewable
Energy and Chemicals business unit at UOP LLC, a wholly-owned subsidiary of Honeywell International.
This group delivers UOP technologies based on renewable resources to the market.
Jennifer earned a bachelor’s of science degree in Chemistry from Harvey Mudd College, a doctorate
degree in Inorganic Materials Synthesis from the University of Illinois at Urbana-Champaign and a MBA
from the University of Chicago. Previous assignments at UOP include the preparation and characterization
of novel zeolites, molecular sieves and layered materials (clays, pillared clays and layered double hydroxides)
and setting up the infrastructure necessary to develop fundamental mechanistic understanding in UOP’s
core areas. Jennifer was a member of the R&D Reengineering Design Team, which redefined UOP’s technology
commercialization methodology. She was the first Chair of R&D’s Technical Community Organization. She
currently serves on multiple external advisory boards. She is the author or co-author of 50 US patents,
31 scientific publications and is the 2003 recipient of the Council for Chemical Research’s (CCR)
Malcolm E. Pruitt Award.
|
| |
 |
Bill Schinski completed his Ph.D.
studies (organic chemistry major; dual physical and biochemistry minors) at
Rutgers U., New Brunswick, NJ in 1968 under Prof. Ron Sauers. His thesis
research described a novel photochemical synthesis and solvolysis of highly
strained “staranes” (five-membered ring homologues of adamantanes). He conducted
post-doctoral research under Prof. Barry Trost at the University of Wisconsin
during 1968-69, demonstrating the d-orbital mechanism for a sulfur extrusion reaction
in a stereo-selective conversion of thietanes to cyclopropanes.
Dr. Schinski joined the Ortho Division of the Chevron Chemical
Company in 1969 before transferring to the Catalyst Group for
the Chevron Research and Technology Company in 1994. He acted as a planning consultant
with Chevron’s Corporate-funded Strategic Research Program to establish major
research initiatives in Bioprocessing, Homogeneous Catalysis, Facilitated and
Ionic Transport Membrane Reactors, Microchannel Reactors, Ionic Liquid Processing,
Fullerene Synthesis/Applications, Diamondoid Synthesis, Direct Methane Conversion and
Hydrocarbon Functionalization. He retired from Chevron in 2005 and now serves as a consultant.
|
|
|
|
|
